Neuroimaging studies of different cognitive profiles in Parkinson's disease

Parkinsonism and Related Disorders

Volumn 18, Issue SUPPL. 1, 2012, Pages

  Monchi, Oury ^a,b   Degroot, Clotilde ^a,b   Mejia Constain, Beatriz ^a   Bruneau, Marie Andrée ^a  

^a CENTRE DE RECHERCHE   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Apathy; Cognition; Depression; Functional and anatomical MRI; Mild cognitive impairment; Parkinson's disease

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; FLUORODEOXYGLUCOSE;

ANATOMICAL VARIATION; APATHY; ARTICLE; BRAIN ATROPHY; BRAIN BLOOD FLOW; CAUDATE NUCLEUS; COGNITION; COMORBIDITY; DEMENTIA; DEPRESSION; EXECUTIVE FUNCTION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; MILD COGNITIVE IMPAIRMENT; NEUROANATOMY; NEUROIMAGING; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; QUALITY OF LIFE; STEADY STATE; SYMPTOM; THALAMUS; VOXEL BASED MORPHOMETRY; BEHAVIOR ASSESSMENT; CLINICAL EVALUATION; ELECTROENCEPHALOGRAM; FUNCTIONAL NEUROIMAGING; IMAGE ANALYSIS; NEUROLOGIC DISEASE ASSESSMENT; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING;

EID: 84858654106     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/s1353-8020(11)70025-6     Document Type: Article

References (20)

1. Poletti M, Emre M, Bonuccelli U, et al., Mild cognitive impairment and cognitive reserve in Parkinson's disease. Parkinsonism Relat Disord 2011;17:579-86.
2. Nordlund A, Rolstad A, Klang O, Edman A, Hansen S, Wallin A. Two-year outcome of MCI subtypes and aetiologies in the Goteborg MCI study. J Neurol Neurosurg Psychiatry 2010;81:541-6.
3. Sollinger AB, Goldstein FC, Lah JL, Levey AI, Stewart A. Factor of Mild cognitive impairment in Parkinson's disease: Subtypes and motor characteristics. Parkinsonism Relat Disord 2010;16:177-80.
4. Playford ED, Jenkins IH, Passingham RE, Nutt J, Frackowiak RS, Brooks DJ. (1992). Impaired mesial frontal and putamen activation in Parkinson's disease: A positron emission tomography study. Ann Neurol 1992;32:151-61.
5. Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. TINS 1989;12:366-75.
6. Owen AM, Doyon J, Dagher A, Sadikot A, Evans AC. Abnormal basal ganglia outflow in Parkinson's disease identified with PET: Implications for higher cortical functions. Brain 1998;121:949-65.
7. Samuel M, Ceballos-Baumann AO, Blin J, Uema T, Boecker H, Passingham RE, Brooks DJ. Evidence for lateral premotor and parietal overactivity in Parkinson's disease during sequential and bimanual movements. A PET study. Brain 1997; 120:963-76.
8. Cools R, Stefanova E, Barker RA, Robbins TW, Owen AM. Dopaminergic modulation of high-level cognition in Parkinson's disease: The role of the prefrontal cortex revealed by PET. Brain 2002;125:584-94.
9. Mattay VS, Tessitore A, Callicott JH, Bertolino A, Goldberg TE, Chase TN, et al. Dopaminergic modulation of cortical function in patients with Parkinson's disease. Ann Neurol 2002;51:156-64.
10. Monchi O, Petrides M, Petre V, Worsley K, Dagher A. Card-sorting revisited: Distinct neural circuits participating in different stages of the task identified by event-related fMRI. J Neurosci 2001;21:7733-41.
11. Monchi O, Petrides M, Doyon J, Postuma R, Worsley K, Dagher A. Neural Bases of Set-shifting Deficits in Parkinson's Disease. J Neurosci 2004;24(3):702-10.
12. Lewis SJ, Dove A, Robbins TW, Barker RA, Owen AM. Cognitive impairments in early Parkinson's disease are accompanied by reductions in activity in frontostriatal neural circuitry. J Neurosci 2003;23:6351-6.
13. Monchi O, Naguno-Saito A, Habak C, Mejia B, Jubault T, Monetta L, Ptito A, Strafella AP. The patterns of fronto-striatal activation during set-shifting in early Parkinson's disease depends on the cognitive profile of the patient. Mov Disord 2011;26(S2).
14. Summerfield C, Junqué C, Tolosa E, Salgado-Pineda P, Gómez-Ansón B, Martí MJ, et al. Structural brain changes in Parkinson disease with dementia: a voxel-based morphometry study. Arch Neurol 2005;62:281-5.
15. Burton EJ, McKeith IG, Burn DJ, Williams ED, O'Brien, JT. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Brain 2004;127:791-800.
16. Meltzer TR, Watts R, Macaskill MR, Pitcher TL, Livingston L, et al. Grey matter atrophy in cognitively impaired Parkinson's disease. J Neurol Neurosurg Psychiatry 2011; [Epub ahead of print]. doi: 10.1136/jnnp-2011-300828.
17. Jubault T, Gagnon J-F, Karama S, Ptito A, Lafontaine A-L, Evans AC, Monchi O. Patterns of cortical thickness and surface area in early Parkinson's disease NeuroImage 2011;55:462-7.
18. Schrag A, Barone P, Brown, RG, Leentjens AFG, McDonald WM, Starkstein S, et al. Depression Rating Scales in Parkinson's Disease: Critique and Recommendations. Movements Disorders 2007;22(8):1077-92.
19. Skidmore FM, Yang M, Baxter L, von Deneen K, Collingwood J, et al. Apathy, depression, and motor symptoms have distinct and separable resting activity patterns in idiopathic Parkinson disease. Neuroimage 2011; http://dx.doi.org/10.1016/j.neuroimage.2011.07.012.
20. Eidelberg D. Metabolic brain networks in neurodegenerative disorders: a functional Imaging approach. TINS 2009;32(10):548-58.